Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
UVA researchers have developed an algorithm that will improve cancer care by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors.
Researchers at the School of Medicine and the UVA Biocomplexity Institute have been selected to help establish a national pathogen genomics surveillance network.
The discovery of a "master controller" for the brain's immune response could let doctors supercharge the body’s ability to fight a spectrum of devastating neurological diseases.
Newly discovered biological changes in mothers who suffer postpartum depression may help explain the condition, yield long-sought treatments and let doctors identify those at risk even before their babies are born.